Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Remedies Ltd - 540937 - Board to consider Bonus Issue

 Medico Remedies Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on October 07, 2021, inter alia, to transact the following business:1. To consider increase in authorized share capital of the Company and subsequent alteration to the Memorandum of Association of the Company;2. To recommend and approve issue of Bonus shares to the equity shareholders of the Company;3. To approve the proposal of Migration of Company from SME platform of BSE to Main Board of BSE Limited as well as on the Main Board of NSE Limited;4. To approve the transactions to be entered into with the related parties of the Company.
30-09-2021
Bigul

Medico Remedies Ltd - 540937 - Board Meeting Intimation for Notice Of Board Meeting

 Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2021 ,inter alia, to consider and approve 1. To consider increase in authorized share capital of the Company and subsequent alteration to the Memorandum of Association of the Company; 2. To recommend and approve issue of Bonus shares to the equity shareholders of the Company; 3. To approve the proposal of Migration of Company from SME platform of BSE to Main Board of BSE Limited as well as on the Main Board of NSE Limited; 4. To approve the transactions to be entered into with the related parties of the Company; and 5. Any other business with the permission of the Chair
30-09-2021
Bigul

Medico Remedies Ltd - 540937 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Medico Remedies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
30-09-2021
Bigul

Medico Remedies Ltd - 540937 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Disclosure on Voting Results of 27th Annual General Meeting of Medico Remedies Limited ('the Company')
30-09-2021
Bigul

Medico Remedies Ltd - 540937 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting the proceedings of 27th Annual General Meeting ('AGM') of Medico Remedies Limited ('the Company') held on Thursday, 30th September, 2021 at 11:00 AM at 1105/1106, 11th Floor, Hubtown Solaris Opp. Telli Galli, N S Phadke Marg, Andheri East, Mumbai 400069
30-09-2021
Bigul

Medico Remedies Ltd - 540937 - Closure of Trading Window

 Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended & Company''s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in its securities, the ''Trading Window'' for dealing in the equity shares of the Company is closed, for all Insiders, Designated Persons and their immediate relatives, from 1st October, 2021 up to the expiry of 48 hours post the date of declaration of the Unaudited Financial Results for the half year ended 30th September, 2021.
30-09-2021
Bigul

Medico Remedies Ltd - 540937 - Intimation For Book Closure For 27Th AGM

 Intimation of Book Closure date pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
08-09-2021
Bigul

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Meeting Updates

 Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, we hereby submit Notice of 27th Annual General Meeting ('AGM') of Medico Remedies Limited ('the Company') to be held on Thursday, 30th September, 2021 at 11:00 AM at 1105/1106, 11th Floor, Hubtown Solaris Opp. Telli Galli, N S Phadke Marg, Andheri East, Mumbai 400069.
08-09-2021
Bigul

Medico Remedies Ltd - 540937 - Reg. 34 (1) Annual Report

 Pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, we hereby submit 27th Annual report for the Financial Year 2020-21.
08-09-2021
Bigul

Medico Remedies Ltd - 540937 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayMedico Remedies Ltd 2CINL24230MH1994PLC077187 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 13.06 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: DINESH MODI Designation: COMPANY SECRETARY EmailId: secretarialmrl@gmail.com Name of the Chief Financial Officer: HARESH MEHTA Designation: CHIEF FINANCIAL OFFICER EmailId: secretarialmrl@gmail.com Date: 16/07/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
16-07-2021
Next Page
Close

Let's Open Free Demat Account